Clinical Trial Update: Tissue-Specific Metabolic Reprogramming in Diabetic Complications [NA]

View source ↗

Summary

This completed clinical trial investigates tissue-specific metabolic reprogramming in diabetic complications associated with Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: University of Michigan | Conditions: Type 1 Diabetes Mellitus | NA | Status: COMPLETED